Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Shabir A. Madhi, Pío López, Betzana Zambrano, Emilia Jordanov, Siham B’Chir, Fernando Noriega & Emmanuel Feroldi. (2019) Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration. Human Vaccines & Immunotherapeutics 15:3, pages 658-668.
Read now
Read now
Pope Kosalaraksa, Kulkanya Chokephaibulkit, Suwat Benjaponpitak, Chitsanu Pancharoen, Sunate Chuenkitmongkol, Siham B'Chir, Xavier Da Costa & Emmanuel Vidor. (2018) Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months. Human Vaccines & Immunotherapeutics 14:5, pages 1257-1265.
Read now
Read now
Rajiv Sharma, Clas Ahlm, Lars Ostergaard, Anthony Dowell, Clément Tran, Stéphane Thomas & Cécile Eymin. (2015) Persistence of immunity in healthy adults aged ≥50 years primed with a hepatitis B vaccine 3 years previously. Human Vaccines & Immunotherapeutics 11:7, pages 1709-1716.
Read now
Read now
Masoomeh Bagheri-Jamebozorgi, Jila Keshavarz, Maryam Nemati, Saeed Mohammadi-Hossainabad, Mohammad-Taghi Rezayati, Mohsen Nejad-Ghaderi, Ahmad Jamalizadeh, Fazel Shokri & Abdollah Jafarzadeh. (2014) The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Human Vaccines & Immunotherapeutics 10:12, pages 3731-3736.
Read now
Read now
Shuaibu A Hudu, Yasmin A Malik, Mohd Taib Niazlin, Nabil S Harmal, Ariza Adnan, Ahmed S Alshrari & Zamberi Sekawi. (2013) Antibody and immune memory persistence post infant hepatitis B vaccination. Patient Preference and Adherence 7, pages 981-986.
Read now
Read now
Yong Poovorawan, Voranush Chongsrisawat, Apiradee Theamboonlers, Priya Diana Crasta, Marc Messier & Karin Hardt. (2013) Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response. Human Vaccines & Immunotherapeutics 9:8, pages 1679-1684.
Read now
Read now
Articles from other publishers (29)
Nasamon Wanlapakorn, Napa Pruetarat, Nasiri Sarawanangkoor, Kanchana Phanphanit, Donchida Srimuan, Thaksaporn Thatsanathorn, Thanunrat Thongmee, Nawarat Posuwan & Yong Poovorawan. (2023) Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age. Vaccine 41:26, pages 3855-3861.
Crossref
Crossref
Huihui Lu, Weihua Cao, Luxue Zhang, Liu Yang, Xiaoyue Bi, Yanjie Lin, Wen Deng, Tingting Jiang, Fangfang Sun, Zhan Zeng, Yao Lu, Lu Zhang, Ruyu Liu, Yuanjiao Gao, Shuling Wu, Hongxiao Hao, Xiaoxue Chen, Leiping Hu, Mengjiao Xu, Qiqiu Xiong, Jianping Dong, Rui Song, Minghui Li & Yao Xie. (2023) Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity. Frontiers in Immunology 14.
Crossref
Crossref
Thanawat Madaeng, Sirisucha Soponkanaporn, Kanchana Tangnararatchakit, Nopporn Apiwattanakul, Chonnamet Techasaensiri, Sophida Boonsathron & Sujittra Chaisavaneeyakorn. (2022) Immunogenicity of Hepatitis B Vaccine in Pediatric Systemic Lupus Erythematosus Patients. Pediatric Infectious Disease Journal 42:1, pages e26-e31.
Crossref
Crossref
Yarong Song, Xin Zhang, Minmin Liu, Xiangjun Zhai, Jianxun Liu, Yi Li, Lili Li, Yiwei Xiao, Zhongping Duan, Jing Jiang, Feng Ding, Liguo Zhu, Jie Jiang, Huaibin Zou, Hui Zhuang, Jie Wang & Jie Li. (2022) A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections. BMC Infectious Diseases 22:1.
Crossref
Crossref
Rossella Tomaiuolo, Umberto Restelli, Francesco Cosimo Faggiano, Chiara Di Resta, Sami Al Bitar Nehme, Francesco Giuliani, Pietro Derrico, Walter Ricciardi, Giuseppe Banfi & Matteo Ritrovato. (2022) Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2. Clinical Chemistry and Laboratory Medicine (CCLM) 60:9, pages 1463-1477.
Crossref
Crossref
Krist Y.H. Ewe, Christopher C. Blyth, Charlie McLeod, Meredith L. Borland, Asha C. Bowen, Daniel K. Yeoh & Anita J. Campbell. (2021) Re-examining Hepatitis B Postexposure Prophylaxis Following Pediatric Community-acquired Needle-stick Injury in an Era of a National Immunization Registry. Pediatric Infectious Disease Journal 41:1, pages 80-84.
Crossref
Crossref
Ashleigh Qama, Nicole Allard, Benjamin Cowie, Joshua S. Davis & Jane Davies. (2021) Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition. Internal Medicine Journal 51:6, pages 910-922.
Crossref
Crossref
Ko Ko, Kazuaki Takahashi, Shintaro Nagashima, Chikako Yamamoto, Vichit Ork, Aya Sugiyama, Tomoyuki Akita, Masayuki Ohisa, Channarena Chuon, Md. Shafiqul Hossain, Bunsoth Mao & Junko Tanaka. (2020) Existence of hepatitis B virus surface protein mutations and other variants: demand for hepatitis B infection control in Cambodia. BMC Infectious Diseases 20:1.
Crossref
Crossref
Ning Miao, Hui Zheng, Xiaojin Sun, Guomin Zhang & Fuzhen Wang. (2020) Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China. Scientific Reports 10:1.
Crossref
Crossref
Takako Inoue & Yasuhito Tanaka. (2020) Cross-Protection of Hepatitis B Vaccination among Different Genotypes. Vaccines 8:3, pages 456.
Crossref
Crossref
Yu-Liang Zhao, Bi-Hua Han, Xin-Jiang Zhang, Lu-Lu Pan, Hai-Song Zhou, Zhao Gao, Zhi-Yong Hao, Zhi-Wei Wu, Tian-Li Ma, Feng Wang, Qi Li, Sheng-Li Bi & Jing-Chen Ma. (2019) Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination. BMC Infectious Diseases 19:1.
Crossref
Crossref
Masataro Norizuki, Tomomi Kitamura, Kenichi Komada, Masaya Sugiyama, Masashi Mizokami, Anonh Xeuatvongsa, Vilasak Som-Oulay, Phengta Vongphrachanh, Munehito Machida, Koji Wada, Koji Ishii, Tomoko Kiyohara, Takaji Wakita & Masahiko Hachiya. (2019) Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People’s Democratic Republic. BMC Infectious Diseases 19:1.
Crossref
Crossref
Christine Durier, Corinne Desaint, Jean-Daniel Lelièvre, Benjamin Silbermann, Gilles Pialoux, Lise Cuzin, Bénédicte Bonnet, Isabelle Poizot-Martin, Amel Bouakane, Christelle Paul, Sophie Grabar, Bruno Spire, Laurence Meyer & Odile Launay. (2019) Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials. AIDS 33:13, pages 2061-2071.
Crossref
Crossref
Pierre Van Damme, Marc Dionne, Geert Leroux‐Roels, Olivier Van Der Meeren, Emmanuel Di Paolo, Bruno Salaun, Pemmaraju Surya Kiran & Nicolas Folschweiller. (2019)
Persistence of
HB
sAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults
. Journal of Viral Hepatitis 26:9, pages 1066-1075.
Crossref
Crossref
Dorcas Obiri-Yeboah, Yaw Asante Awuku, George Adjei, Obed Cudjoe, Anna Hayfron Benjamin, Evans Obboh & Daniel Amoako-Sakyi. (2019) Post Hepatitis B vaccination sero-conversion among health care workers in the Cape Coast Metropolis of Ghana. PLOS ONE 14:6, pages e0219148.
Crossref
Crossref
Jia-Feng Wu & Yen-Hsuan Ni. 2019. Viral Hepatitis in Children. Viral Hepatitis in Children
103
114
.
Nawarat Posuwan, Arnond Vorayingyong, Vorapol Jaroonvanichkul, Rujipat Wasitthankasem, Nasamon Wanlapakorn, Sompong Vongpunsawad & Yong Poovorawan. (2018) Implementation of hepatitis B vaccine in high-risk young adults with waning immunity. PLOS ONE 13:8, pages e0202637.
Crossref
Crossref
H. LI, G. J. LI, Q. Y. CHEN, Z. L. FANG, X. Y. WANG, C. TAN, Q. L. YANG, F. Z. WANG, F. WANG, S. ZHANG, S. L. BI & L. P. SHEN. (2017) Long-term effectiveness of plasma-derived hepatitis B vaccine 22–28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?. Epidemiology and Infection 145:5, pages 887-894.
Crossref
Crossref
Yong Joo Kim, Peipei Li, Jong Myeon Hong, Keun Ho Ryu, Eunwoo Nam & Mi Soo Chang. (2017) A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea. Journal of Korean Medical Science 32:5, pages 810.
Crossref
Crossref
H. CHAOUCH, W. HACHFI, I. FODHA, O. KALLALA, S. SAADI, A. BOUSAADIA, F. LAZRAG, I. BOUGMIZA, M. AOUNI, A. TRABELSI, E. BEN JAZIA & A. LETAIEF. (2016) Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia. Epidemiology and Infection 144:16, pages 3365-3375.
Crossref
Crossref
Michael G. Bruce, Dana Bruden, Debby Hurlburt, Carolyn Zanis, Gail Thompson, Lisa Rea, Michele Toomey, Lisa Townshend-Bulson, Karen Rudolph, Lisa Bulkow, Philip R. Spradling, Richard Baum, Thomas Hennessy & Brian J. McMahon. (2016) Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. Journal of Infectious Diseases 214:1, pages 16-22.
Crossref
Crossref
Nawarat Posuwan, Nasamon Wanlapakorn, Pattaratida Sa-nguanmoo, Rujipat Wasitthankasem, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Viboonsak Vuthitanachot, Siriporn Sae-lao, Monthana Foonoi, Apinya Fakthongyoo, Jamorn Makaroon, Klaita Srisingh, Duangporn Asawarachun, Somchai Owatanapanich, Norra Wutthiratkowit, Kraisorn Tohtubtiang, Pornsak Yoocharoen, Sompong Vongpunsawad & Yong Poovorawan. (2016) The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation. PLOS ONE 11:3, pages e0150499.
Crossref
Crossref
Geert Leroux-Roels. (2014) Old and new adjuvants for hepatitis B vaccines. Medical Microbiology and Immunology 204:1, pages 69-78.
Crossref
Crossref
Andréa do Livramento, Júnia Schultz, Keila Zaniboni Siqueira Batista, Arício Treitinger, Caio Maurício Mendes de Cordova & Celso Spada. (2014) Immune memory response induced in vitro by recombinant hepatitis B surface antigen challenge 13-18 years after primary vaccination. Journal of Medical Virology 86:10, pages 1700-1704.
Crossref
Crossref
David J. Templeton, Phillip Read, Rajesh Varma & Christopher Bourne. (2014) Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence. Sexual Health 11:3, pages 217.
Crossref
Crossref
Celine A. Hayden. 2014. Commercial Plant-Produced Recombinant Protein Products. Commercial Plant-Produced Recombinant Protein Products
197
228
.
Salyavit Chittmittrapap, Thaweesak Chieochansin, Roongruedee Chaiteerakij, Sombat Treeprasertsuk, Naruemon Klaikaew, Pisit Tangkijvanich, Piyawat Komolmit & Yong Poovorawan. (2013) Prevalence of Aflatoxin Induced p53 Mutation at Codon 249 (R249s) in Hepatocellular Carcinoma Patients with and without Hepatitis B Surface Antigen (HBsAg). Asian Pacific Journal of Cancer Prevention 14:12, pages 7675-7679.
Crossref
Crossref
Anna Kaltsas & Kent Sepkowitz. (2013) Vaccinations for healthcare personnel. Current Opinion in Infectious Diseases 26:4, pages 366-377.
Crossref
Crossref
David FitzSimons, Greet Hendrickx, Alex Vorsters & Pierre Van Damme. (2013) Hepatitis B vaccination: A completed schedule enough to control HBV lifelong?. Vaccine 31:4, pages 584-590.
Crossref
Crossref